Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: serrano lopez j. Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11. Br J Cancer. 2024. PMID: 38467828 Free PMC article.
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: serrano lopez j. Br J Cancer. 2024 May;130(8):1414. doi: 10.1038/s41416-024-02667-x. Br J Cancer. 2024. PMID: 38575733 Free PMC article. No abstract available.
Large-scale production of superparamagnetic iron oxide nanoparticles by flame spray pyrolysis: In vitro biological evaluation for biomedical applications.
Estévez M, Cicuéndez M, Crespo J, Serrano-López J, Colilla M, Fernández-Acevedo C, Oroz-Mateo T, Rada-Leza A, González B, Izquierdo-Barba I, Vallet-Regí M. Estévez M, et al. Among authors: serrano lopez j. J Colloid Interface Sci. 2023 Nov 15;650(Pt A):560-572. doi: 10.1016/j.jcis.2023.07.009. Epub 2023 Jul 4. J Colloid Interface Sci. 2023. PMID: 37429163 Free article.
Programming of neural progenitors of the adult subependymal zone towards a glutamatergic neuron lineage by neurogenin 2.
Péron S, Miyakoshi LM, Brill MS, Manzano-Franco D, Serrano-López J, Fan W, Marichal N, Ghanem A, Conzelmann KK, Karow M, Ortega F, Gascón S, Berninger B. Péron S, et al. Among authors: serrano lopez j. Stem Cell Reports. 2023 Dec 12;18(12):2418-2433. doi: 10.1016/j.stemcr.2023.10.019. Epub 2023 Nov 22. Stem Cell Reports. 2023. PMID: 37995703 Free PMC article.
Identifying prognostic gene panels in acute myeloid leukemia.
Sanchez-Garcia J, Serrano J, Prados de La Torre E, Serrano-López J, Aparicio-Perez C, Barragán E, Montesinos P. Sanchez-Garcia J, et al. Among authors: serrano lopez j. Expert Rev Hematol. 2023 Apr;16(4):277-287. doi: 10.1080/17474086.2023.2193322. Epub 2023 Mar 29. Expert Rev Hematol. 2023. PMID: 36951195 Review.
Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma.
Velasco-Rodríguez D, Martínez-Alfonzo I, Velasco-Valdazo AE, Revilla N, Mahíllo-Fernández I, Askari E, Castro-Quismondo N, Laso RV, Domingo-González A, Serrano-López J, Prieto E, Rosado B, Blanchard MJ, Martín-Herrero S, García-Raso A, Bueno MÁ, de la Plaza R, Peñaherrera M, López IG, López-Jiménez J, Martínez-López J, Llamas-Sillero P. Velasco-Rodríguez D, et al. Among authors: serrano lopez j. J Thromb Thrombolysis. 2023 Apr;55(3):464-473. doi: 10.1007/s11239-022-02765-8. Epub 2023 Jan 11. J Thromb Thrombolysis. 2023. PMID: 36630029
Editorial: Driving extracellular vesicles toward applications in precision medicine.
Chutipongtanate S, Pattanapanyasat K, Meller J, Serrano López J. Chutipongtanate S, et al. Among authors: serrano lopez j. Front Med (Lausanne). 2022 Nov 22;9:1049697. doi: 10.3389/fmed.2022.1049697. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36482912 Free PMC article. No abstract available.
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
Castaño-Bonilla T, Barragán E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, García-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-López J, Martínez-López J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Castillo TB, Larrayoz MJ, Amigo R, Jiménez-Velasco A, Sánchez J, Ayala R, Blas C, Lainez D, Serrano-López J, Sanz MA, Alonso-Domínguez JM, Montesinos P. Castaño-Bonilla T, et al. Among authors: serrano lopez j. Dis Markers. 2022 Aug 23;2022:3132941. doi: 10.1155/2022/3132941. eCollection 2022. Dis Markers. 2022. PMID: 36051360 Free PMC article.
36 results